Turkey is one of the countries with statistical evidence of inadequate morphine consumption per capita. In 2006, the adequacy of opioid analgesic consumption was only 6% - based on a per capita consumption of 6.76 morphine equivalents (mEq) while 118 mg would have been adequate. Turkey was selected as one of the countries to participate in the ATOME project due to this factor. Four years later, in 2010, the adequacy of opioid analgesic consumption had slightly increased (both in absolute and in relative terms) – but was still only 7% (based on a per capita consumption of opioid analgesics of 14.31 morphine equivalents (mEq) while 196.50 mEq in mg per capita would have been adequate). This report presents a summary of the results of the situational analysis that has been undertaken with regard to opioid availability and accessibility in Turkey. The results of the situational analysis are divided in two parts: the first part addresses legal and regulatory issues and the second part focuses on issues relating to policy. Both parts present the main barriers and recommendations for improving access to opioid medication in Turkey.